Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Nov 14, 2024 7:30 AM - Nov 15, 2024 4:10 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Early Bird Rates Expire






Meeting: November 14-15, 2024 | In-Person

The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Safety and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and safety and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.

While we develop our 2024 agenda, please take a moment to review the 2023 final agenda


Need Approval in Order to Attend?

Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.

Participant Testimonials

What a wonderful event to get up to speed on the latest regulatory and industry developments for drugs and devices, directly from experts and leaders in the field, that includes a number of opportunities to network and get to know speakers and presenters. – Kelly McClellan - Federal Government Canada

Excellent meeting, the presenters from industry and Health Canada were knowledgeable and fully engaged. – Patricia Smith – Otsuka

The quality of the presentations was high and all information discussed was relevant for our job. The ambience was favourable for discussions and great interaction among participants. – Celline Brasil – Health Canada


Want to learn more about Canada Annual Meeting? You've come to the right site!


Highlights & Features

Who should attend?

  • Meeting Designed For:

    Join professionals interested in a comprehensive overview of the current biopharma pharmaceutical, medical device, and/or diagnostics landscape in Canada:

    • Pharmacovigilance and Drug Safety
    • Risk Management
    • Clinical Research, Management, and Operations
    • Regulatory Affairs and Operations
    • Medical Affairs and Scientific Communication
    • Quality Assurance
    • Life Sciences R&D
    • Project Management
    • Real-World Data and Real-World Evidence
    • Data Management

Program Committee

  • Stephanie  Anderson
    Stephanie Anderson Associate Director, Regulatory Affairs
    Intrinsik Corp., Canada
  • Rebecca  Barnes, MS
    Rebecca Barnes, MS Executive Director
    Network of Networks (N2), Canada
  • Vatche  Bartekian, MSc
    Vatche Bartekian, MSc President
    Vantage BioTrials, Canada
  • Katalin  Bertenyi
    Katalin Bertenyi Manager, Centre for Blood, Blood Products and Biotherapeutics
    Health Canada, Canada
  • Louise  Blythe, MSc
    Louise Blythe, MSc VP & Head, Regulatory Affairs
    Bayer Inc. Canada, Canada
  • Melanie  Cote, MS
    Melanie Cote, MS Senior Manager, Regulatory Affairs
    Otsuka, Canada
  • My  Dang, MBA
    My Dang, MBA Director/Consultant, Regulatory Affairs
    Cencora, Canada
  • Zohra  Douida, MPharm, MS, MSc
    Zohra Douida, MPharm, MS, MSc Head, Regulatory Affairs Canada
    Indivior Canada Inc., Canada
  • Tharany  Ganesh
    Tharany Ganesh Head, Regulatory Affairs
    AstraZeneca Canada Inc., Canada
  • Marie-France  Goyer, MSc
    Marie-France Goyer, MSc Director, Clinical Operations
    Abcellera, Canada
  • Daniel  Greco, PharmD, RPh
    Daniel Greco, PharmD, RPh Associate Director of Patient Safety
    Bristol-Myers Squibb Company, Canada
  • Brenda  Gryfe, MSc
    Brenda Gryfe, MSc Director, Regulatory Affairs
    TPIreg, Innomar Strategies, Canada
  • Oxana  Iliach, PhD
    Oxana Iliach, PhD Senior Director Regulatory Strategy
    Certara, Canada
  • Nadiya  Jirova, MSc
    Nadiya Jirova, MSc Manager, Bureau of Biologics, Radiopharmaceuticals and Self-Care Products
    Health Canada, Canada
  • Mei  Lam, BSN, RN
    Mei Lam, BSN, RN Canada PV Manager/Safety Regional Country Contact
    Haleon, Canada
  • Randy  Levitt, PhD
    Randy Levitt, PhD Director, Pharmacovigilance and Medical Affairs
    Paladin Pharma Inc., Canada
  • Amber  McLeod, PhD
    Amber McLeod, PhD Immunology, Virology, and Specialty Head, Regulatory Affairs
    Abbvie Corporation, Canada
  • Nadia  Mian, MS
    Nadia Mian, MS Pharmacovigilance Manager
    Ipsen Biopharmaceuticals Canada Inc., Canada
  • Myriam  Salem, MSc
    Myriam Salem, MSc Pharmacovigilance Manager
    Health Canada, Canada
  • Marcia  Sam
    Marcia Sam Regulatory Affairs Strategy and Policy Manager
    Hoffmann-La Roche Canada Limited, Canada
  • Vanessa  Zapata
    Vanessa Zapata Associate Director, Regional Pharmacovigilance Officer
    Merck Canada Inc., Canada
  • Representative Invited
    Representative Invited DIA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.